Jiangsu Chinagreen Biological Technology Group Co., Ltd. Class A

Jiangsu Chinagreen Biological Technology Group Co., Ltd. Class A

SSZSE:300970
11.45
CNY
-0.24
(-2.05%)
0.61EPS
36.45P/E
2.79BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
3.81
4.7
2.91
2.34
3.07
3.45
5.06
4.6
4.02
4.95
6.57
6.84
8.38
9.09
Basic EPS, GAAP
0.51
0.91
0.66
0.56
0.57
0.49
1.06
1
0.11
0.52
0.2
-0.32
0.72
0.48
Free Cash Flow per Basic Share
0.1
-0.22
0.71
- -
-0.84
-1.13
1.02
0.06
-0.84
-1.5
-0.38
-0.86
1.44
- -
Dividend per Share
0.31
0.31
0.21
0.2
0.17
0.14
0.24
0.22
0.25
0.02
0.23
0.22
0.07
0.47
Book Value per Share
0.69
1.02
1.4
4.71
5.2
5.42
6.48
7.45
9.42
9.96
10.1
9.55
10.27
9.91
Tangible Book Value per Share
0.65
0.97
1.35
4.63
4.86
5.01
6.02
6.98
9.07
9.62
9.72
9.18
9.92
9.57
Basic Weighted Avg Shares
39
41
83
114
113
114
114
133
144
152
152
151
154
157
Sales/Revenue/Turnover
150
194
241
266
348
394
575
609
578
752
996
1,032
1,292
1,423
Operating Margin (%)
18.9
23.68
27.4
25.24
19.48
15.25
22.2
21.97
0.95
9.67
4.87
-2.02
10.41
8.07
Depreciation Expense
11
14
23
1
41
54
73
76
84
99
134
168
200
- -
Net Income, GAAP
20
38
54
63
64
56
121
133
16
78
30
-48
110
75
Effective Tax Rate (%)
0.02
- -
0.01
0.45
1.06
0.74
0.14
0.11
3.02
2.9
- -
- -
0.04
0.04
Profit Margin (%)
13.32
19.4
22.59
23.8
18.43
14.15
20.97
21.74
2.68
10.41
3.05
-4.61
8.54
5.27
Working Capital
-66
-56
-50
208
117
-46
189
199
748
525
394
357
589
641
LT Debt
34
49
20
20
- -
42
123
133
213
228
270
517
500
672
Total Equity
79
127
173
554
603
617
737
851
1,438
1,523
1,568
1,519
1,672
1,631
Return on Invested Capital (%)
- -
16.22
20.85
13.62
10.31
8.09
14.69
13.87
1.19
4.42
1.46
- -
5.72
- -
Return on Capital (%)
- -
21.89
23.95
14.08
10.96
10.89
19.26
15.06
1.32
4.58
2.32
- -
5.42
- -
Return on Common Equity (%)
- -
38.61
39.45
18.2
11.37
9.24
17.83
16.72
1.36
5.32
1.98
-3.13
7.05
- -

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
71
31
8
LT Borrowings
287
283
287
LT Finance Leases
189
386
385
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
159
159
160
Market Capitalization
2,869
2,901
2,790

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
954
858
824
Cash, Cash Equivalents & STI
695
589
550
Accounts Receivable, Net
21
15
20
Inventories
232
248
247
Total Current Liabilities
231
204
183
Payables & Accruals
- -
- -
- -
ST Debt
71
31
8
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
35.03%
16.95%
10.04%
Free Cash Flow
- -
-343.75%
-270.37%
Net Income, GAAP
-20.24%
-66.67%
-331.82%
Sales/Revenue/Turnover
19.28%
17.24%
25.17%
Total Cash Common Dividend
116.05%
216.09%
-65.61%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
257
206
273
297
1,032
2025
271
228
- -
424
1,292
2026
414
280
305
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.02
-0.31
0.06
-0.08
-0.32
2025
0.01
-0.36
- -
0.6
0.72
2026
0.7
-0.41
-0.41
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.02
0.17
0.02
0.02
0.22
2025
0.01
0.03
- -
0.02
0.07
2026
0.02
0.4
0.03
- -
- -

Company Description

CEO
Yang Chao Yu
Full Time Employees
2,388
Sector
Process industries
Industry
Agricultural commodities/Milling
Address
Suqian China
IPO Date
Apr 12, 2021
Business
Jiangsu Chinagreen Biological Technology Group Co., Ltd. is a China-based agricultural biotechnology company primarily engaged in the industrialized research, development, factory cultivation, processing, and commercial distribution of fresh edible fungi. The company's product portfolio comprises fresh enoki mushrooms (Flammulina velutipes); white beech mushrooms; brown beech mushrooms (crab-flavor mushrooms); seafood mushrooms; king oyster mushrooms; specialty fresh edible mushroom varieties; and by-product agricultural organic substrate materials. It provides factory-scale controlled-environment cultivation, automated cold-chain logistics, standardized fresh packaging, and wholesale supply services to agricultural wholesale markets, modern retail supermarket chains, foodservice operators, and fresh food e-commerce platforms. Founded in 2010 and headquartered in Suqian, Jiangsu Province, China, the company operates modernized industrialized cultivation and processing facilities across key domestic agricultural hubs, including Jiangsu, Hebei, Henan, Heilongjiang, and Chongqing, serving regional and nationwide markets throughout China as well as select export destinations. In recent developments, Jiangsu Chinagreen Biological Technology Group has advanced its multi-base nationwide production strategy by expanding and commissioning large-scale intelligent edible fungi production facilities in Chongqing and northeastern China, significantly increasing its daily cultivation capacity. The company has also strategically diversified its product mix by scaling up high-value specialty mushroom varieties alongside its core enoki mushroom line. Furthermore, the company has integrated automated liquid spawn inoculation technologies, IoT-driven intelligent climate-control cultivation systems, and automated sorting and packaging lines across its modern factory bases to enhance production efficiency and yield consistency.